SEC Form 4 · accession 0001364719-26-000004
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Kauffman
Director
Period of report
Jun 12, 2026
Accepted (ET)
Jun 17, 2026 · 7:40 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000921299
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $7.13 | Jun 12, 2026 | A | 7,000 | A | — | Jun 11, 2036 | Common Stock | 7,000 | 7,000 | D |
Explanation of responses
- F1The shares subject to the option shall vest in four equal quarterly installments measured from the date of grant.